AnoukIn den Kleef

Associate

Amsterdam + 31.20.305.4247

Anouk In den Kleef's practice focuses on legal, tax, and regulatory matters regarding private funds including private equity, buyout, real estate, and debt funds. She advises on fund formation, which includes structuring, marketing, fund governance, documenting, and registration, in investor negotiations and has in-depth experience in Know Your Customer (KYC) laws regarding the onboarding process before closing a fund.

She has handled numerous fund reviews for investors such as NN Group N.V., Bluemetric, Van Lanschot Kempen Investment Management, and Van Lawick Capital and has advised various clients on fund formations such as Gilde Healthcare Partners, Capital A Management, Holland Capital Management, Ice Lake Management, BPD RCF Fundmanagement, and Beaureale Investments.

Expérience

  • Greystar launches Dutch Essential Housing VentureJones Day advised Greystar in the establishment of its Dutch Essential Housing Venture in partnership with Stichting Pensioenfonds ABP (through its asset manager, APG Asset Management N.V.).
  • Holland Capital completes €225 million fundraising Holland Capital Growth & Buy Out Fund VJones Day advised Holland Capital on its €225 million fundraising fifth growth and buyout fund, Holland Capital Growth & Buy Out Fund V.
  • Beaureale advised on post-establishment fundraising on cross border basis of Dutch fund structureJones Day is advising Beaureale on the post-establishment fundraising in the Netherlands, Germany, France and Belgium of a Dutch fund structure, to be managed on a cross border basis by Beaureale Group's French AIFM.
  • Climate Fund Managers forms Climate Investor ThreeJones Day advised Climate Fund Managers on the formation of Climate Investor Three, a funding platform for the purpose of investing in energy transition infrastructure companies in the green hydrogen value chain.
  • Gilde Healthcare VI raises €740 millionJones Day represented Gilde Healthcare in connection with the establishment of Gilde Healthcare Venture & Growth VI with €740 million in commitments.
  • IceLake Capital Management B.V. closes IceLake Capital Fund IIJones Day advised IceLake Capital Management B.V. on the fundraising of its second private equity fund, IceLake Capital Fund II, an investment fund for the purpose of investing in small- and medium-sized companies with sustainable competitive advantages and solid growth prospects, with a general focus on the business services and software sectors in the Benelux, closing at €315 million.
  • Capital A completes fundraising of Capital A Fund IVJones Day advised Capital A Management, a specialized mid-market private equity investor, in relation to the fundraising of its Benelux focused private equity fund, Capital A Fund IV.
  • Gilde Healthcare establishes Gilde Healthcare Private Equity IVJones Day advised Gilde Healthcare Partners B.V. in the establishment of Gilde Healthcare Private Equity IV, a private equity fund that invests in profitable healthcare companies operating in the lower mid-market in North-west Europe.
  • Cygnum Capital extends AIFMD licenseJones Day advised Cygnum Capital on the extension of Cygnum Capital's AIFMD license in order to manage public debt funds/feeder AIFs in private and/or public debt.
  • Climate Fund Managers announces first close of CI2, its second global climate fund, at $675 millionJones Day represented Climate Fund Managers (CFM) with the structuring, establishment, fund raising and first closing of the new fund, CI2 Construction Equity Fund, that invests in water, sanitation and oceans infrastructure projects in Africa, South and South East Asia, and Latin America.
  • Greystar announces €725 million close for flagship pan-European closed-end value-add residential strategyJones Day advised Greystar Europe Investment Management B.V., a subsidiary of Greystar Real Estate Partners, LLC, on the closing of €725 million in equity commitments into its flagship pan-European value-add discretionary vehicle.
  • Gilde Healthcare V raises €416 million for its venture and growth capital fundJones Day represented Gilde Healthcare in connection with the establishment of Gilde Healthcare V, a venture & growth capital fund that invests in digital and home health, medtech, diagnostics, research tools and instruments, and therapeutics.